Please login to the form below

Not currently logged in
Email:
Password:

Bedrock appoints new commercial director

Dr Laura Ciccolini brings experience from the Biopharm Group and Sigma Aldrich

Bedrock Healthcare Communications Dr Laura CiccolinaUK-based medical communications agency Bedrock has appointed Dr Laura Ciccolini to be its new commercial director.

She has over 15 years experience in life sciences and biochemical engineering and previously served as a business development manager for chemical, life science and biotech company Sigma Aldrich.

Her prior roles also include executive director and commercial director at pharma and biotech equipment supplier the Biopharma Group.

In her new senior management position at Bedrock she will be tasked with supporting and driving the agency's growth, working across its insights, med comms and multimedia practices.

Ciccolini will report to CEO David Youds, who said: “I am delighted Laura has joined our team and brings such strong experience.

“Laura will be instrumental in shaping the way we connect with clients and their audiences, as well as providing commercial leadership within the agency to ensure we meet our goals as an organisation.”

21st September 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics